Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 55 (9) , 1233-1251
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Application of probabilistic neural network in the clinical diagnosis of cancers based on clinical chemistry dataAnalytica Chimica Acta, 2002
- Comparison of prediction models for adverse outcome in pediatric meningococcal disease using artificial neural network and logistic regression analysesJournal of Clinical Epidemiology, 2002
- A preliminary evaluation of neural network analysis for pharmacodynamic modeling of the dosing of the hydroxymethylglutaryl coenzyme a-reductase inhibitors simvastatin and atorvastatinClinical Therapeutics, 2002
- Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.Pharmaceutical Research, 2002
- Empirical versus mechanistic modelling: Comparison of an artificial neural network to a mechanistically based model for quantitative structure pharmacokinetic relationships of a homologous series of barbituratesAAPS PharmSci, 1999
- Artificial Neural Networks Applied to the In Vitro-In Vivo Correlation of an Extended-Release Formulation: Initial Trials and ExperienceJournal of Pharmaceutical Sciences, 1999
- Application of Neural Networks to Population Pharmacokinetic Data AnalysisJournal of Pharmaceutical Sciences, 1997
- Artificial Neural Networks As a Novel Approach to Integrated Pharmacokinetic—Pharmacodynamic AnalysisJournal of Pharmaceutical Sciences, 1996
- Quantitative Structure–Pharmacokinetic Relationships (QSPR) of Beta Blockers Derived Using Neural NetworksJournal of Pharmaceutical Sciences, 1995
- Feasibility of Developing a Neural Network for Prediction of Human Pharmacokinetic Parameters from Animal DataPharmaceutical Research, 1993